Skip to main content

NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.

Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.

U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

A Global Partnership Advancing Biopharmaceutical Development: Summary and Future Perspectives

Published

Author(s)

John E. Schiel, Michael J. Tarlov, Karen W. Phinney, Oleg Borisov, Darryl Davis

Abstract

Not applicable
Citation
State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization, Volume 3: Defining the Next Generation of Analytical and Biophysical Techniques
Volume
3
Publisher Info
American Chemical Society, Washington DC, DC

Keywords

Biopharmaceutical, monoclonal antibody, reference material

Citation

Schiel, J. , Tarlov, M. , Phinney, K. , Borisov, O. and Davis, D. (2015), A Global Partnership Advancing Biopharmaceutical Development: Summary and Future Perspectives, State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization, Volume 3: Defining the Next Generation of Analytical and Biophysical Techniques, American Chemical Society, Washington DC, DC, [online], https://doi.org/10.1021/bk-2015-1202.ch015 (Accessed October 20, 2025)

Issues

If you have any questions about this publication or are having problems accessing it, please contact [email protected].

Created October 15, 2015, Updated November 10, 2018
Was this page helpful?